Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 9:22 PM ET

Pharmaceuticals

Company Overview of SciClone Pharmaceuticals, Inc.

Executive Profile

Nancy T. Chang Ph.D.

Independent Director, Member of Corporate Governance Committee and Member of Business Development Committee, SciClone Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 Board Members in 13 different organizations across 16 different industries.

See Board Relationships
65$108,976

Background

Dr. Nancy T. Chang, Ph.D. serves as the President at Apex Enterprise, Inc. Dr. Chang served as a Chairperson and Senior Managing Director of Caduceus Asia Partners at OrbiMed Advisors L.L.C. She served as Consultant and Venture Partner at PTV Sciences, L.P. She served as the President of Tanox Inc. from March 1986 to February 2006 and served as its Chief Executive Officer from June 1990 to February 2006 addressing the medical needs in the areas of asthma, allergy, inflammation ...

Corporate Headquarters

950 Tower Lane
Foster City, California 94404

United States

Phone: 650-358-3456
Fax: 650-358-3469

Board Members Memberships

Director
Director
Independent Director and Member of Nominating & Governance Committee
Director
Board of Directors
Director and Member of Corporate Board
Chiarperson and Senior Managing Director of Caduceus Asia Partners
Director
Director
Member of Scientific Advisory Board and Director
2010-Present
Director
2013-Present
Independent Director, Member of Corporate Governance Committee and Member of Business Development Committee

Education

Doctorate
Harvard University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$58,000
Total Calculated Compensation$108,976
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.1M
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$555.2K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$643.4K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
$814.6K
Allan Oberman Chief Executive Officer and Director
Sagent Pharmaceuticals, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SciClone Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.